
Conference Coverage
about 12 hours ago
AAOpt 2026: Current controversies in macular hole diagnosis, management10 days ago
AAOpt 2026: GLP-1RAs and ocular healthLatest Content

AAOpt 2026: Jeffrey Walline, OD, PhD, on his conference takeaways

AAOpt 2026: Current controversies in macular hole diagnosis, management

The screen time question: What to ask and when to look deeper

AAOpt 2026: Kevin Chan, OD, on low-dose atropine for myopia management

AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa

Shorts










Podcasts
Videos
Optometry Times Digital Edition




All News

A single Epioxa epi-on cross-linking treatment sustained a 1.9 D Kmax improvement through three years in keratoconus, with no serious adverse events reported.

Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.

IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.

Magdalena Stec, OD, FAAO; Noreen Shaikh, OD, FAAO; Huizi Kelly Yin, OD, FAAO; and Brenda Bohnsack, MD, PhD, detail their AAOpt 2026 session in Anaheim, California.

Kwaku Osei, OD, PhD, FAAO, discussed patient-reported outcomes with a senofilcon C (Johnson & Johnson; Acuvue Vita), reusable lens, with the majority of wearers rating comfort, vision, and handling favorably.

Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, discussed how oculomics research presented at AAOpt 2026 could eventually support point-of-care diagnosis and referral decisions.

Lloyd Williams, MD, PhD, discusses rising cataract blindness and low-cost surgery in conflict zones for World Sight Day.

A handful of eye care providers spoke on the factors that have led to a lack of eye care access for World Sight Day.

Jacob Lang, OD, FAAO, details his AAOPt 2026 poster presentation "Rapid and Durable Redness Relief with a Novel Brimonidine Tartrate Ophthalmic Solution Containing Hyaluronic Acid."

Amber Carissa "A.C." Flynn details a case in her AAOpt 2026 poster that demonstrates successful ocular surface optimization for a patient with several eye conditions.

Kevin Chan, OD, MS, FAAO, FBCLA, IACMM, stated in his Rapid Fire lecture that high myopes shouldn't be counted out of orthokeratology treatment.

Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.

Mohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, details his AAOpt 2026 presentation "Photobiomodulation in Age-Related Macular Degeneration: Evidence, Mechanisms, and Clinical Integration."

Magdalena Stec, OD, FAAO, and Noreen Shaikh, OD, MEd, FAAO, gave an overview of current evidence-based myopia control treatments in part of their AAOpt 2026 session.

Eric Schmidt, OD, FAAO, presented his poster "Patient-Reported Blurred Vision Improvement with Cyclosporine 0.1%/PFBP in Dry Eye Disease with Severe Central Corneal Staining: Phase 3 Pool" at AAOpt 2026.





























